baber/WOPTO huggingface dataset:
Patent EP-0650747-B1 (EP)
Inventor: JODELET FRANCOIS
IPC: A63C5/12
Filed: 1994-09-06
Granted: 1998-06-03
Abstract: Method for moulding a ski in a single stage, consisting:   . in depositing at least one layer of inner reinforcement (13, 14) in the bottom of a mould; . in positioning an upper reinforcement layer (22) composed of mechanisation elements over this lower assembly (10); . in placing a protective and decorative layer (21) over this upper reinforcement layer (22);   . in closing the cover (lid) of the mould; . in injecting a fluid intended to expand the various elements against the walls, between the lower assembly (10) and upper assembly (22); characterised in that at least one additional element (30) intended to vary the relative position of the mechanisation elements of the said reinforcement layer (22) with respect to the faces of the ski is positioned at the level of the upper reinforcement layer (22). <IMAGE>
Patent EP-0623071-B1 (EP)
Title: Plaque de metal revetue presentant une variation facile de brillance et bloquage thermique limite pendant la stratification, et son procede de preparation
Inventor: NAKAZAWA TOKUAKI
IPC: B05D7/24
Filed: 1993-11-22
Granted: 2001-01-17
Abstract: Des tôles possédant une couche de peinture au fluorure de polyvinylidène durcie (2) sur la surface métallique (1) et une couche de peinture à l'éthylène vinyl éther fluorée et durcie (3) sur la peinture au fluorure de polyvinylidène présentent d'excellentes propriétés de résistance aux intempéries, une brillance de 25 à 80 %, et peuvent être incurvées jusqu'en un angle aigu sans craquèlement du revêtement. Ces tôles sont particulièrement utiles dans la préparation de stratifiés composites métal-résine, étant donné qu'elles ne sont pas soumises à un blocage thermique pendant l'étape de stratification.
Patent EP-0673296-B1 (EP)
Inventor: FARWER ALFWARD
IPC: B23K35/38
Filed: 1993-12-02
Granted: 1997-03-26
Abstract: In the TIG and MIG welding of aluminium, high-purity argon or high-purity argon/helium mixtures are used as the inert gas. In order to improve the welding process and the result obtained, the invention proposes that 80 to 250 vpdm, preferably 120 to 180 vpdm, of N2/N2O are added to the inert gas. Any ratio of N2 to N2O may be used.
Patent EP-0683774-B1 (EP)
Inventor: BRIEADDY LAWRENCE EDWARD
IPC: C07D281/10
Filed: 1994-02-15
Granted: 2002-10-09
Abstract: PCT No. PCT/GB94/00314 Sec. 371 Date Aug. 15, 1995 Sec. 102(e) Date Aug. 15, 1995 PCT Filed Feb. 15, 1994 PCT Pub. No. WO94/18184 PCT Pub. Date Aug. 18, 1994The invention provides novel 1,4-benzothiazepine compounds substituted with hydroxy or a group containing hydroxy, compositions comprising such compounds and their use in the treatment or prophylaxis of treating clinical conditions in which inhibition of bile acid uptake is indicated, for example, hyperlipidemia and atherosclerosis.
Patent EP-0685054-B1 (EP)
Inventor: ZURMUEHLEN GUENTER
IPC: F22G5/12
Filed: 1994-02-14
Granted: 1997-01-08
Abstract: The steam desuperheating valve has a housing (4) with a steam inlet (1), a cooling water inlet (3) and a steam outlet (2). In the housing (4) there are a perforated basket (11) forming a depressurising chamber and an axially movable control piston (5) controlling the flow of steam and cooling water to the depressurising chamber. The control piston (5) is rigidly coupled to a perforated cylinder (6) axially movable in the perforated basket (11). This perforated cylinder (6) releases or blocks the steam inlet (D) into the perforated basket (11) and the steam outlet into a second depressurising chamber (10) arranged around the perforated basket (11). Into the perforated basket (11) projects a coaxial nozzle pipe (14) which is connected outside the perforated basket (11) to the cooling water inlet (3). Inside the perforated basket (11) the nozzle pipe (14) has injection apertures (15) for the cooling water (W). Outside the perforated basket (11) the nozzle pipe (14) projects into the steam outlet (2) and has an injection nozzle (16) at that point for the cooling water (W). A first piston section (7) movable with the control piston (5) in the nozzle pipe (14) alternately opens and closes the injection apertures (15) in the nozzle pipe (14). A second piston section (8) regulates the cooling water inlet (3) in the size of the through-flow cross-section (X) for the flow of cooling water into the injection apertures (15) in the depressurising chamber and/or into the injection nozzle (16) in the steam outlet (2). The second depressurising chamber (10) surrounding the perforated basket (11) is connected via through-flow apertures (17) to the steam outlet (2) forming a third depressurising chamber.
Patent EP-0731731-B1 (EP)
Inventor: BUNCE ROGER ABRAHAM
IPC: B01L3/00
Filed: 1994-02-23
Granted: 1997-08-06
Abstract: An analytical device (1) for use in assay procedures comprises at least one liquid flow channel of porous material leading from a channel end to an analytical site (2) via a localised reagent site (3). A liquid-impermeable barrier (6) is arranged adjacent to the reagent site (3) in the liquid flowpath to slow the transport of the reagent to the analytical site (2) by creating a relatively stagnant zone (10) which has the effect of elongating the distribution of reagent in the liquid flow.
Patent EP-0688312-B1 (EP)
Inventor: MAKOVEC FRANCESCO
IPC: A61K31/535
Filed: 1994-03-02
Granted: 1998-11-18
Abstract: PCT No. PCT/EP94/00604 Sec. 371 Date Sep. 11, 1995 Sec. 102(e) Date Sep. 11, 1995 PCT Filed Mar. 2, 1994 PCT Pub. No. WO94/20454 PCT Pub. Date Sep. 15, 1994Compounds represented by general formula (I) and (II), in which r is 1 or 2, R2 and R3 are selected independently from H, CH3, C2H5 and CHO, provided that R2 and R3 are not simultaneously CHO, and in which R1 is selected from: an aminoalkyl adamantyl group, a monocyclic aminoalkyl group, a dicyclic aminospiro group, a dicyclic amino group (orthofused), a dicyclic amino group, and azacycloalkyl group, an azadicyclic group (orthofused), a dicyclic azaspiro group, and azadicyclic group, and azacycloalkyl group, and a linear or branched aminoalkyl group.
Patent EP-0689468-B1 (EP)
Inventor: JANSEN LEX PHILIP
IPC: A61M25/01
Filed: 1994-03-14
Granted: 2001-10-04
Abstract: A small diameter steerable guidewire adapted for use in percutaneous transluminal coronary angioplasty has three segments, each adapted to reside in a separate region of the arterial and coronary anatomy during angioplasty. The proximal segment is adapted to reside proximally of the aortic arch and has high torsional rigidity for enhanced pushability and rotational transmission. An intermediate segment is adapted to reside in the region of the aortic arch and is more flexible than the proximal section while maintaining a high degree of rotation transmission. The distal segment is more flexible than the intermediate segment and is dimensioned to reside from a region proximally of the primary curve of the guidewire to and into the coronary arteries.
Patent EP-0703756-B1 (EP)
Inventor: IMRAN MIR A
IPC: A61B18/18
Filed: 1994-05-31
Granted: 2004-12-15
Abstract: A transurethral radio frequency apparatus for ablation of the prostate gland through the urethra formed by a wall, a probe consisting of a flexible elongate tubular member with proximal and distal extremities and sized so as to be adapted to be inserted into the urethra, and an ablation electrode carried by the distal extremity of the flexible elongate member. The flexible elongate tubular member is provided with first and second flow lumens for delivering a cooled fluid to the ablation electrode to cool the same. Means are connected to the probe to supply a coolant solution to the probe, to supply radio frequency energy to the electrode while it is being cooled, and to monitor the temperature of the ablation electrode so that the ablation electrode is maintained at a temperature below a predetermined temperature to spare the urethral wall from irreversible damage from the radio frequency energy delivered to the ablation electrode.
Patent EP-0712544-B1 (EP)
Inventor: LILLINGTON PAUL EVAN
IPC: H02K5/04
Filed: 1994-07-19
Granted: 2000-10-25
Abstract: PCT No. PCT/AU94/00405 Sec. 371 Date Jan. 18, 1996 Sec. 102(e) Date Jan. 18, 1996 PCT Filed Jul. 19, 1994 PCT Pub. No. WO95/03646 PCT Pub. Date Feb. 2, 1995A motor or alternator comprises a number of permanent magnets (34, 36) arranged about the periphery of a rotor (30). The magnets (34, 36) are encompassed by stator coils (44) pressed over and supported on the stator housing (41) between fins (39). The magnets (34, 36) are arranged with their like poles facing each other while the stator coils (44) are arranged in a C-shape or a U-shape configuration about the permanent magnets allowing the magnets (34, 36) to rotate within the toroidal space defined by the stator coils (44). The rotor (30) is made of a non-magnetic material which may include an electrical conductor such as aluminum or a highly resistive material such as a plastics material. The number of stator coils (44) will depend on the phase excitation used (a 3-phase motor is described) with the commutation of the coils being supplied either mechanically or electronically. In the latter case rotor position is sensed by vanes (61) of a shutter housing (60), rotating with the shaft (42), interrupting light from the diode (64) to the photoelectric detector (62). Other embodiments may employ Hall effect sensors, or the stator coils (44) and the magnets (34, 36) may be located at an inner radius of the rotor, the rotor then being annular in form, or to one or more of the sides of a discoid rotor.
Patent EP-0713463-B1 (EP)
Inventor: TALBOT DENNIS W
IPC: B63B35/73
Filed: 1994-07-21
Granted: 2002-02-13
Abstract: Bateau (110) polyvalent comprenant un ou plusieurs logements formés dans la partie de poupe qui servent à amarrer un autre bateau personnel (BP) (100). Le bateau personnel (100) est connecté de manière à assurer la propulsion d'un engin naval polyvalent (110) lorsqu'il est amarré de la sorte dans le logement. Le bateau polyvalent (110) et le BP (100) peuvent être séparés et utilisés de manière indépendante lorsqu'ils flottent sur l'eau. Le BP (100) peut également être amarré dans le logement associé du bateau polyvalent (110) lorsque ce dernier flotte sur l'eau. Cette invention concerne également la possibilité de naviguer sur le bateau polyvalent (110). Un mât (68), des gouvernails et une dérive-sabre (92) peuvent être installés sur le bateau lorsque ce dernier flotte sur l'eau afin que le bateau polyvalent (110) puisse utiliser l'énergie du vent comme force de propulsion. Le bateau polyvalent (110) peut passer en mode de navigation à voile que le BP (100) soit ou non amarré dans son logement.
Patent EP-0723465-B1 (EP)
Inventor: ALLONEN HANNU
IPC: A61M5/178
Filed: 1994-09-16
Granted: 2000-02-09
Abstract: The surface (21) of the plunger and the inner wall (15) of the implant housing are equipped with interacting members (22,12) which allow the plunger to be pushed inwards into the implant housing while preventing the removal of the plunger from the implant housing. The cannula is made of plastic. The surface of the plunger is equipped with a member (22) which allows the displacement of the plunger inwards into the implant housing and that the rim or edge (12) of the implant housing distal to the cannula is shaped so that the inner cross-sectional area of the implant housing is reduced at point (16). The edge acts as a stop for the element on the surface of the plunger when the plunger is displaced outwards.
Patent EP-0720454-B1 (EP)
Inventor: JOHANSSON THOMAS
IPC: A61F2/00
Filed: 1994-08-05
Granted: 1999-11-24
Abstract: Implant intended to be fixed through contact with new grown bone tissue comprising a dense material having an implant surface, and having, at least within a surface portion of the implant surface, surface pores covering at least 5% of the surface portion. The surface pores constitute a contact surface for new grown bone tissue, wherein close to at least a substantial fraction of all of the surface pores has at least one elevation extending over the implant surface which completely or at least partially surrounds an edge of the pore. Each elevation has a rough surface which causes formation of soft tissue when the implant surface is in contact with newly growing bone tissue.
Patent EP-0711879-B1 (EP)
Inventor: MONTEITH JOSEPH GORDON
IPC: E03F5/12
Filed: 1995-11-08
Granted: 2005-02-23
Abstract: A tank interceptor comprises a container enclosing a circular chamber divided by a horizontal partition (22) into a bypass compartment (24) above and a treatment compartment (26) below. The sidewall has an inlet opening (30) and an outlet opening (32), both disposed above the partition (22), which includes a raised portion (40) isolating the openings (30, 32) from each other. Apertures (54, 56) through the partition (22) disposed on either side of the raised portion (40) are each provided with a downwardly extending pipe. Liq. entering the bypass chamber via the inlet (30) passes through the opening (54) into the treatment chamber (26) where non-aq. materials are collected, and up through the aperture (56) back into the bypass compartment and out through the outlet (32).
Patent EP-0701031-B1 (EP)
Inventor: ROUX ANNETTE
IPC: E04B1/343
Filed: 1995-09-07
Granted: 1998-08-12
Abstract: The mobile home is made in two sections (1), each of which has a reinforced zone (2) in its side facing the opposite section. The two reinforced zones are joined together by a floor surface (6) which can be covered in by a roof and wall panels. The floor surface between the two sections can be used as a landing or terrace, and the principle can be extended so that more than two sections can be joined together.
Patent EP-0673830-B1 (EP)
Title: Body framework
Inventor: WALDECK KLAUS-DIETER
IPC: B61D17/00
Filed: 1995-03-09
Granted: 1999-11-17
Abstract: In a box skeleton with an outer covering contg. flat multilayer covering elements, the elements are two-layered, the first layer being a support of high strength material and the second layer being a plastics plate which is tightly bonded to the support and which has a smooth outer surface. The support is fitted to the box skeleton and the plastics plate forms the large area smooth outside of the high structural strength outer covering. Pref. the support is a metal sheet and the plastics plate consists of a rigid closed-cell polymer foam contg. PVC or polycarbonate. Also claimed are (i) a process for prodn. of outer coverings for the above box skeleton; (ii) a car box including a box skeleton with an outer covering as described above; and (iii) road and rail vehicle car boxes including a box skeleton with an outer covering as described above.
Patent EP-0736216-B1 (EP)
Inventor: HAUNER FRANZ
IPC: H01H1/02
Filed: 1994-12-14
Granted: 1997-09-03
Abstract: On propose de plus en plus des matériaux de substitution pour les pièces de contact de commutateurs basse tension qui jusqu'à maintenant étaient souvent constituées d'argent-nickel. Afin d'améliorer la capacité de commutation d'un tel matériau de substitution, qui contient outre l'argent au moins de l'oxyde de fer (Fe2O3/Fe3O4) et de l'oxyde de zirconium (ZrO2) comme composants actifs, pour ce qui est de l'intensité du courant limite de soudage, on y ajoute un autre oxyde du sixième groupe secondaire du système périodique et/ou un oxyde mixte constitué d'oxyde de fer et d'un oxyde d'un élément du sixième groupe secondaire du système périodique. Cet additif supplémentaire est notamment du ferro-wolframate (FeWO4).
Patent EP-0741715-B1 (EP)
Inventor: HIEBERT CHARLES K
IPC: C07D265/26
Filed: 1995-01-20
Granted: 1998-08-26
Abstract: L'invention concerne de nouveaux agents thérapeutiques utiles en tant qu'inhibiteurs de HLE. Les composés présentent la formule structurelle (I), dans laquelle R1 à R9, m, n et p sont définis dans la description. L'invention concerne également des procédés d'utilisation des composés de la formule (I) afin d'inhiber des sérine-protéases et afin de traiter des états physiologiques ainsi que des états pathologiques associés à des niveaux élevés de HLE, ainsi que des compositions pharmaceutiques contenant lesdits composés.
Patent EP-0744993-B1 (EP)
Inventor: GAERDIN MATS
IPC: A23L5/30
Filed: 1995-02-14
Granted: 2000-06-07
Abstract: PCT No. PCT/SE95/00153 Sec. 371 Date Sep. 5, 1996 Sec. 102(e) Date Sep. 5, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO95/21690 PCT Pub. Date Aug. 17, 1995A high-pressure and a method for high-pressure treatment of substances. The high-pressure press comprises a high-pressure cylinder consisting of a number of concentrically arranged cylinder elements (1, 2, 3). The cylinder elements (1, 2, 3) are radially prestressed to a predetermined prestress and surround a high-pressure chamber (6) for accommodating a pressurized medium. A thin safety liner (3), which is intended to be placed in the high-pressure cylinder until a fracture arises on the safety liner (3), is arranged in the interior of the high-pressure cylinder. Further, means (14, 15) are provided to conduct at least part of the pressurized medium from the high-pressure chamber (6) when a fracture arises on the safety liner (3). The means (14, 15) comprise at least one channel (14) running essentially along the outer envelope surface of the safety liner (3). The method comprises using the high-pressure press without liner replacement until a fracture has occurred on the thin safety liner.
Patent EP-0756804-B1 (EP)
Inventor: WATERS DONALD GEORGE PAUL
IPC: H04Q3/00
Filed: 1995-04-21
Granted: 2001-11-14
Abstract: Un système de création de services pour un réseau de communications du type réseau intelligent possède 3 niveaux différents dans lesquels des activités de création de services peuvent être effectuées, et qui sont appelés SCE1, SCE2 et SCE3. L'utilisation de niveaux séparés permet de maintenir fonctionnellement séparé l'accès au système de création de services pour les utilisateurs ayant des intérêts différents dans le réseau. Ainsi, les fonctions, qui devront être installées au niveau élémentaire du réseau d'un service sélectionné disponible, peuvent être créées en SCE1. Des fonctions de services commercialisables, qui donnent une vue des fonctions en ce sens qu'elles comprennent une logique de traitements d'appels ainsi que des descriptions de support et de gestion, peuvent être créés soit en SCE2. Des ensembles de services, qui permettent de rassembler des fonctions de services commercialisables afin de faire face aux besoins d'un service, ainsi que des informations relatives à la gestion et aux supportts spécifiques de services, peuvent être créés soit en SCE2 soit en SCE3. Des profils, qui répertorient les fonctions relatives à un service d'un utilisateur et assurent de petits espaces disponibles pour les données nécessaires à chaque fonction, peuvent être placés et modifiés en SCE3.
Patent EP-0760091-B1 (EP)
Inventor: ESSENPREIS MATTHIAS
IPC: A61B5/145
Filed: 1995-05-03
Granted: 1999-11-03
Abstract: Procédé pour la détermination analytique de la concentration d'un analyte dans un échantillon biologique, selon lequel, en premier lieu, dans une phase de détection, un faisceau lumineux est envoyé dans l'échantillon sous forme de faisceau primaire, par des moyens d'irradiation, au travers d'une couche limite délimitant l'échantillon biologique, et la lumière émise par l'échantillon biologique est détectée, sous forme de faisceau secondaire, par des moyens de détection, à une distance de mesure prédéterminée, en tant que grandeur de mesure, en vue de déterminer les propriétés physiques variables de la lumière, par suite de l'interaction avec les propriétés biologiques, grandeur qui est en corrélation avec la concentration de l'analyte dans l'échantillon biologique, puis, dans une phase d'évaluation, on détermine la concentration dudit analyte, sur la base de la grandeur mesurée lors de la phase de détection. En vue d'obtenir une bonne précision de mesure sans réactif, et non-invasive, le procédé selon l'invention est caractérisé en ce que, dans la phase de détection: (a) des mesures spectroscopiques dans le domaine fréquentiel sont effectuées avec au moins deux trajets différents de lumière mesurée, entre les points d'irradiation et de détection, sans déplacement des moyens d'irradiation ou des moyens de détection; (b) chacune des mesures spectroscopiques dans le domaine fréquentiel est effectuée à au moins deux longueurs d'onde différentes; et (c) lors des mesures spectroscopiques dans le domaine fréquentiel, on détermine le déphasage du faisceau secondaire par rapport au faisceau primaire, ainsi qu'une valeur de l'intensité.
Patent EP-0727490-B1 (EP)
Inventor: TANABE TADASHI
IPC: C07K16/40
Filed: 1995-04-27
Granted: 2006-06-28
Abstract: A DNA comprising a DNA having a nucleotide sequence encoding the amino acid sequence of human-originated prostacyclin synthase (PGIS) substantially depicted in Sequence No. 12, a vector comprising said DNA, a host cell transformed with said vector and a method for preparing human-originated PGIS comprising culturing said host cell in a medium. A polypeptide having the amino acid sequence of human-originated PGIS substantially depicted in Sequence No. 12 and an antibody having a reactivity with said human-originated PGIS. A pharmaceutical composition comprising said DNA or a vector comprising said DNA. A method for promoting the production of PGI2 and a method for treating the diseases induced by a low production of PGI2, comprising introducing said DNA or a vector comprising said DNA into human or other animals. The present invention clarifies the primary structure of human-originated PGIS and the nucleotide sequence encoding same. The PGIS and its DNA are useful as reagents for the development of therapeutic agents for the cardiovascular diseases induced by the production imbalance between PGI2 and TXA2, and as diagnostics for determining the in vivo tissue expression level and distribution of PGIS or mRNA thereof. Moreover, they can be used as therapeutic agents for cardiovascular diseases, which introduce PGIS and the like into human or other animals in a lesion-specific manner. The production method of the present invention is useful for the easy and efficient mass production of the human-originated PGIS. The antibody of the present invention is useful for the purification of the human-originated PGIS and immunohistochemical analysis of the cause of a disease.
Patent EP-0706481-B1 (EP)
Inventor: CASSOU BERTRAND
IPC: B65B43/12
Filed: 1995-05-04
Granted: 1999-03-17
Abstract: PCT No. PCT/FR95/00582 Sec. 371 Date Feb. 21, 1996 Sec. 102(e) Date Feb. 21, 1996 PCT Filed May 4, 1995 PCT Pub. No. WO95/30579 PCT Pub. Date Nov. 16, 1995A device for packaging liquids, particularly animal semen, in pre-scaled and pre-cut pouches provided in a roll and designed for artificial insemination. The device includes a tiltable table with a base enabling adjustment of the tilt angle of the table to facilitate gravitational filling of pouches, a pouch filling station and a sealing station. The device also includes a movable filling needle inserted into a removable needle guide and mounted on a block that includes an inductive proximity sensor for generating an alternating magnetic field which is automatically stopped when a metal liner is inserted into the needle guide following needle insertion into the pouch. Cessation of the alternating magnetic field triggers the sealing of the pouch.